$471.37 travel Payment -- AbbVie Inc to Dr. Paul Turner

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

AbbVie Inc made a $471.37 travel payment to Paul Turner, a Dermatology specialist in City, IN. The payment was associated with Xtandi. AbbVie Inc. paid $471.37 for travel and lodging expenses related to Xtandi. The payment was made on March 9, 2026, to Dr. Paul Turner, a dermatologist. This payment falls under the 'travel' category, covering associated travel and lodging.

Patient Guidance: What This Payment Means for You

This payment covered travel and lodging expenses for your physician related to a pharmaceutical product. You can ask your doctor if this travel was for educational purposes or to attend a conference. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in dermatology, often associated with educational events or conferences related to specific drugs like Xtandi.

Regulatory Context: Sunshine Act Requirements

This payment is reported under the Open Payments program, which requires disclosure of financial relationships between drug and device manufacturers and physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-payments
• travel-expenses
• dermatology
• abbvie
• xtandi

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $471.37 payment for?

This was a travel payment of $471.37 from AbbVie Inc to Paul Turner, categorized as "Travel and Lodging". It was associated with Xtandi. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Paul Turner accept pharmaceutical money?

Yes, Paul Turner received this $471.37 payment from AbbVie Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Paul Turner's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $471.37 should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Dermatology?

To compare this payment against Dermatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Dermatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Paul Turner's relationship with AbbVie Inc?

The payment amount is relatively small, suggesting it may cover a single trip or event. This $471.37 travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Dermatology?

The payment is specifically for 'Travel and Lodging', indicating it's not for speaking fees or consulting.

What should patients do after learning about this payment?

This payment covered travel and lodging expenses for your physician related to a pharmaceutical product. You can ask your doctor if this travel was for educational purposes or to attend a conference.

What else should I know about this travel payment?

The drug associated with the payment is Xtandi, a prostate cancer medication.

Related Reports

• View Dr. Paul Turner's full payment report
• AbbVie Inc full spending report
• Browse all Dermatology payments
• Browse all payments in Indiana
• Search for other payments